f.weiss

TL2 Moderator · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 5 April 2025 · last posted 3d

85 posts, newest first. Showing up to 150.

Tracking intake honestly when appetite is absent Replied, post #113 · Nutrition & Training › Protein & intake · 25 Jul 2026 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #34 · Clinical › Bloodwork · 24 Jul 2026 · 9 likes I read post #32 twice before replying, because I had assumed the opposite. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ…
Pooling trials with different estimands Replied, post #118 · Evidence › Meta-analyses · 22 Jul 2026 · 0 likes I read post #116 twice before replying, because I had assumed the opposite. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #135 · Practice › Reconstitution · 22 Jul 2026 · 23 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
Why the Start Here categories exist, and what they are not for Replied, post #22 · Start Here › Welcome · 21 Jul 2026 · 7 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #88 · Analytics › Impurities & related substances · 18 Jul 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #47 · Pharmacology › Receptor biology · 17 Jul 2026 · 6 likes I read post #45 twice before replying, because I had assumed the opposite. Species differences: rodent studies show the same compounds produce effects in rodents that…
Retatrutide mass and identity: what a report should show Replied, post #17 · Compounds › Retatrutide · 14 Jul 2026 · 20 likes Worth separating two things that post #13 runs together. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material…
What to bring: records that a clinician can actually use — a second dataset Replied, post #29 · Clinical › Prescriber conversations · 12 Jul 2026 · 0 likes On post #25 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #18 · Practice › Side effects · 12 Jul 2026 · 23 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #32 · Start Here › Welcome · 11 Jul 2026 · 0 likes I read post #30 twice before replying, because I had assumed the opposite. Your introduction is well framed. You have given enough context that people can actually…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #66 · Access › Insurance & coverage · 10 Jul 2026 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
I have no scientific background — can I still follow the analytics categories? Replied, post #27 · Start Here › Welcome · 26 Jun 2026 · 19 likes On post #23 — agreed on the reasoning, with one qualification. Trust levels accumulate over time and they give you access to small things like the ability to edit your…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #30 · Analytics › Impurities & related substances · 28 May 2026 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
Second pass at: Metformin co-administration and additive GI effects Replied, post #109 · Practice › Interactions · 21 May 2026 · 15 likes I read post #107 twice before replying, because I had assumed the opposite. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #42 · Analytics › Impurities & related substances · 20 May 2026 · 1 like Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
Shoulders, tangent skims, and defensible integration Started this topic · Analytics › HPLC & UHPLC · 9 May 2026 · 0 likes Posting this under the heading it deserves: Shoulders, tangent skims, and defensible integration Everything below is what sits behind that. Posting the method first,…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #83 · Devices › Syringes & needles · 3 May 2026 · 30 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #106 · Compounds › Tirzepatide · 2 May 2026 · 12 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
About the Insurance & coverage category Replied, post #4 · Access › Insurance & coverage · 25 Apr 2026 · 20 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Micro-titration: a disputed topic, argued properly Replied, post #55 · Practice › Dosing & titration · 3 Apr 2026 · 27 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #16 · Practice › Interactions · 27 Mar 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Designing a personal experiment that could change your mind — one year on Replied, post #25 · Research Methods › N-of-1 designs · 25 Mar 2026 · 0 likes Coming back to post #23, because the follow-up matters more than the original answer. Sample size in n-of-1: you are the sample. Repeated measurements (weekly…
What a certificate commits its issuer to — one year on Replied, post #36 · Analytics › COA interpretation · 22 Mar 2026 · 1 like When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Primary endpoint hierarchies and why order matters Replied, post #3 · Evidence › Trials · 20 Mar 2026 · 3 likes I read the opening post twice before replying, because I had assumed the opposite. Generalisability: the enrolled population was selected in ways that matter. Entry…
Second pass at: The topic list is dense — is that deliberate? Replied, post #93 · Meta › Site feedback · 8 Mar 2026 · 29 likes Picking up post #90: that is the part I would want checked first. Community norms: if you think a norm has drifted or is not being followed consistently, raising it…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #93 · Clinical › Bloodwork · 6 Mar 2026 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
Contributing data without breaching anyone's privacy Replied, post #30 · Data & Tools › Datasets · 4 Mar 2026 · 0 likes post #29 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Request: export my own posts — one year on Replied, post #53 · Meta › Feature requests · 1 Mar 2026 · 19 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #37 · Analytics › Impurities & related substances · 24 Feb 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Liver enzymes drifting down and what that usually means Replied, post #59 · Clinical › Bloodwork · 21 Feb 2026 · 1 like Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #59 · Practice › Dosing & titration · 18 Feb 2026 · 7 likes post #58 answers the question as asked. The question underneath it is different. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #7 · Sourcing › Vendor reports · 2 Feb 2026 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #68 · Documentation › Wiki requests · 2 Feb 2026 · 0 likes Picking up post #65: that is the part I would want checked first. Correction requests: if you spot an error in a maintained page, note it here with the specific…
Coverage in the US: a map of the usual obstacles Replied, post #44 · Regional › North America · 31 Jan 2026 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #17 · Outcomes › Body composition · 23 Jan 2026 · 5 likes Coming back to post #15, because the follow-up matters more than the original answer. Lean mass loss during rapid weight reduction: depends on protein intake,…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #37 · Pharmacology › Receptor biology · 1 Jan 2026 · 3 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #117 · Practice › Reconstitution · 11 Dec 2025 · 14 likes This follows post #114 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
Filter needles: when they help and what they cost you Started this topic · Devices › Syringes & needles · 5 Dec 2025 · 0 likes On the subject in the title: Filter needles: when they help and what they cost you Working notes rather than a conclusion. A question about technique rather than about…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #26 · Compounds › Tirzepatide · 3 Dec 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Personal import allowances, compared — a second dataset Replied, post #27 · Access › International · 26 Nov 2025 · 18 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #44 · Analytics › Impurities & related substances · 23 Nov 2025 · 29 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #2 · Practice › Reconstitution · 22 Nov 2025 · 27 likes This follows the opening post rather than contradicting it. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives…
Prescription requirements and telehealth models Replied, post #23 · Sourcing › Regulatory · 20 Nov 2025 · 22 likes Coming back to post #21, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
Temperature loggers worth the money — the long version Replied, post #70 · Devices › Cold chain · 7 Nov 2025 · 2 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
Sleep quality changes during weight loss — what changed since Replied, post #54 · Wellbeing › Sleep · 7 Nov 2025 · 0 likes Coming back to post #52, because the follow-up matters more than the original answer. Sleep quality versus quantity: some people report changes to sleep duration;…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #84 · Documentation › Doc review · 30 Oct 2025 · 3 likes Worth separating two things that post #80 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
New subcategory: rationale and scope Replied, post #62 · Meta › Announcements · 19 Oct 2025 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members…
A parcel that arrived warm: a decision process, not a verdict Replied, post #91 · Practice › Storage & stability · 18 Oct 2025 · 8 likes post #90 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #111 · Practice › Side effects · 2 Oct 2025 · 0 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #17 · Evidence › Preprints · 26 Sep 2025 · 9 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #8 · Evidence › Preprints · 25 Sep 2025 · 30 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
Dead volume across syringe and needle combinations Replied, post #3 · Devices › Syringes & needles · 20 Sep 2025 · 1 like post #2 is right about the mechanism and I think understates the practical bit. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #2 · Analytics › Method validation · 9 Jul 2025 · 12 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #62 · Clinical › Comorbidities · 30 Jun 2025 · 0 likes I read post #60 twice before replying, because I had assumed the opposite. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is…
Coming back to: When "no data" is the complete and final answer Replied, post #28 · Compounds › Other compounds · 29 Jun 2025 · 20 likes This follows post #25 rather than contradicting it. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same…
Counter-ion content and its effect on measured mass Replied, post #66 · Analytics › Mass spectrometry · 16 Jun 2025 · 12 likes Worth separating two things that post #62 runs together. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the…
Sequence verification for an obscure compound: how it is done Replied, post #58 · Compounds › Other compounds · 9 Jun 2025 · 1 like Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
Which panel is worth repeating and which is worth ignoring Replied, post #31 · Clinical › Bloodwork · 3 Jun 2025 · 17 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #97 · Sourcing › Red flags · 18 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #2 · Devices › Pens & autoinjectors · 26 Apr 2025 · 2 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
When to suspect the method rather than the sample Replied, post #115 · Analytics › Method validation · 15 Apr 2025 · 9 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Journal club: SURMOUNT-1, read without the press release Replied, post #91 · Evidence › Journal club · 5 Apr 2025 · 6 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Retatrutide dose escalation in the published trials Replied, post #79 · Compounds › Retatrutide · 2 Apr 2025 · 3 likes On post #75 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Coverage for the indication versus for the drug Replied, post #15 · Access › Insurance & coverage · 31 Mar 2025 · 0 likes Picking up post #12: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #65 · Practice › Reconstitution · 28 Mar 2025 · 5 likes post #64 is right about the mechanism and I think understates the practical bit. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
Review: a draft on reconstitution arithmetic, with objections Replied, post #74 · Documentation › Doc review · 25 Mar 2025 · 22 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
Coverage for the indication versus for the drug — a second dataset Replied, post #38 · Access › Insurance & coverage · 24 Mar 2025 · 13 likes post #37 is right about the mechanism and I think understates the practical bit. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #127 · Pharmacology › Receptor biology · 19 Mar 2025 · 2 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #96 · Sourcing › Vendor reports · 18 Mar 2025 · 25 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #75 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes post #74 answers the question as asked. The question underneath it is different. Blind submission is worth the effort: have someone else relabel the sample so neither…
Reading order for a first week here, and what to skip until later Replied, post #31 · Start Here › Welcome · 10 Mar 2025 · 13 likes This follows post #28 rather than contradicting it. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is…
Scheduled maintenance and what will be unavailable Replied, post #56 · Meta › Announcements · 27 Feb 2025 · 33 likes Worth separating two things that post #52 runs together. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what…
Cost per milligram, computed honestly across formats — the long version Replied, post #19 · Access › Pricing · 26 Feb 2025 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #136 · Evidence › Journal club · 22 Feb 2025 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
[2026 update] US compounding rules and how they changed Started this topic · Regional › North America · 14 Feb 2025 · 10 likes US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated,…
Prior authorisation: what the criteria usually require Replied, post #2 · marked as the solution · Access › Insurance & coverage · 31 Jan 2025 · 18 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #20 · Analytics › COA interpretation · 18 Jan 2025 · 31 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
Triple agonism: additive, synergistic, or neither? Replied, post #11 · Compounds › Retatrutide · 17 Jan 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
[2026 update] New subcategory: rationale and scope Replied, post #95 · Meta › Announcements · 26 Dec 2024 · 18 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
Washout with a one-week half-life: the arithmetic Replied, post #69 · Research Methods › N-of-1 designs · 5 Dec 2024 · 3 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #65 · Compounds › Repair & healing peptides · 16 Nov 2024 · 2 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #6 · Practice › Interactions · 5 Sep 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
SURPASS-2 and the comparator dose question that will not go away Replied, post #3 · Compounds › Tirzepatide · 19 Aug 2024 · 17 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #4 · Analytics › Method validation · 23 Jul 2024 · 2 likes Picking up post #2: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…